Association of serum MMP-9 with autoantibodies against oxidized LDL

Atherosclerosis

Volumn 160, Issue 1, 2002, Pages 161-165

  Kalela, A ^a   Koivu, T A ^a   Höyhtyä, M ^b   Jaakkola, O ^a   Lehtimäki, T ^c   Sillanaukee, P ^a   Nikkari, S T ^a,c  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b Diabor Oy   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Angina pectoris; Autoantibodies; Matrix metalloproteinase 9; Oxidized LDL

Indexed keywords

AUTOANTIBODY; CHOLESTEROL; GELATINASE B; HIGH DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ANALYTIC METHOD; ANGINA PECTORIS; ANTIBODY BLOOD LEVEL; ARTERY; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; INFLAMMATION; LIPID OXIDATION; MACROPHAGE; MAJOR CLINICAL STUDY; PLAGUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING HABIT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANGINA PECTORIS; AUTOANTIBODIES; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL, HDL; FINLAND; HUMANS; LIPOPROTEINS, LDL; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 0036145230     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00553-6     Document Type: Article

References (32)

1. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques
2. Matrix metalloproteinases and coronary artery disease: A novel therapeutic target
3. Pathophysiology and inflammatory aspects of plaque rupture
4. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques
5. Reactive oxygen species, metalloproteinases, and plaque stability
6. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: Association of active enzyme synthesis with unstable angina
7. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis
8. Association of serum sialic acid and MMP-9 with lipids and inflammatory markers
9. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages
10. Low density lipoprotein undergoes oxidative modification in vivo
11. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL
12. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease
13. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction
14. Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty
15. 72 kD and 92 kD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: A study by in situ hybridization
16. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus
17. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): A major international collaboration
18. Metal ion release from mechanically disrupted human arterial wall. Implications for the development of atherosclerosis
19. Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis
20. Human monocytes/macrophages release TNF-alpha in response to Ox-LDL
21. Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis
22. PPARgamma agonists enhance human vascular endothelial adhesiveness by increasing ICAM-1 expression
23. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages
24. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis
25. Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease
26. Specificity of autoantibodies against oxidized LDL as an additional marker for atherosclerotic risk
27. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction
28. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls
29. Antibody titers against oxidized LDL are not elevated in patients with familial hypercholesterolemia
30. Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects
31. Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population
32. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis